Curran Simpson

Insider Reports History

Entity
Individual
Location
C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Curran Simpson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Executive Officer, Director Common Stock 170K $2.55M $15.00 Aug 1, 2024 Direct
REGENXBIO Inc. Chief Executive Officer, Director Stock Options (Right to Buy) 272K Jul 1, 2024 Direct

Insider Reports Filed by Curran Simpson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Aug 1, 2024 1 -$1.5K 4 Aug 5, 2024 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jul 29, 2024 1 -$145K 4 Jul 30, 2024 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jul 1, 2024 2 $0 4 Jul 3, 2024 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jan 2, 2024 3 -$146K 4 Jan 4, 2024 Chief Oper. & Tech. Officer
RGNX REGENXBIO Inc. Jan 3, 2023 3 -$47.1K 4 Jan 5, 2023 Chief Oper. & Tech. Officer
RGNX REGENXBIO Inc. Jan 1, 2022 3 -$43.6K 4 Jan 4, 2022 Chief Oper. & Tech. Officer